Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Pertussis Vaccine Market Growth Evolved From 2024 To 2025, And What’s Ahead?

In recent times, we have observed a constant growth in the size of the pertussis vaccine market. Predictions indicate an increase from $5.5 billion in 2024, to $5.65 billion in 2025, which signifies a compound annual growth rate (CAGR) of 2.9%. Factors such as disease prevalence, immunization schemes, pediatric vaccination, and regulatory approvals, have contributed to the growth we’ve seen in the historic period.

The market size for the pertussis vaccine is predicted to experience consistent growth in the forthcoming years, reaching $6.49 billion in 2029 with a compound annual growth rate (CAGR) of 3.5%. The expected growth in the forecast period can be linked to factors such as booster vaccinations, maternal immunizations, immunizations for healthcare workers, and worldwide health initiatives. Noteworthy trends for the predicted period involve personalized vaccine schedules, combination vaccines, initiatives to equalize vaccine access, and the use of digital health for immunization.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13023&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Pertussis Vaccine Market?

The increase in birth rates is propelling the expansion of the pertussis vaccine market. Childbirth, the process of delivering a baby, signifies the end of pregnancy and the start of a new existence outside the womb. The pertussis vaccine is predominantly administered to children as it safeguards them from whooping cough and other dangerous diseases that could be lethal. For example, in January 2023, a report from the Centers for Disease Control and Prevention, a public health institution in the US, revealed a 1% rise in recorded births in the United States, amounting to 3,664,292 in comparison to the prior year. As a result, the escalating birth rates are fueling the pertussis vaccine market’s expansion.

Which Primary Segments of the Pertussis Vaccine Market Are Driving Growth and Industry Transformations?

The pertussis vaccine market covered in this report is segmented –

1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine

2) By Vaccine Type: Whole-Cell Vaccine, Acellular Vaccine

3) By Application: Children, Adults, Infants

4) By End-User: Vaccination Centers, Hospitals, Clinics

Subsegments:

1) By DTaP (Diphtheria, Tetanus, And Acellular Pertussis) Vaccine: Pediatric DTaP Vaccine, Combination Vaccines With DTaP

2) By Tdap (Tetanus, Diphtheria, And Pertussis) Vaccine: Adolescent Tdap Vaccine, Adult Tdap Vaccine

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13023&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Pertussis Vaccine Market?# Market?

North America was the largest region in the pertussis vaccine market in 2024. The regions covered in pertussis vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Most Significant Market Trends in the Pertussis Vaccine Market?

Leading firms in the pertussis vaccine market, such as UK-based GSK plc, are actively developing groundbreaking drugs and gaining necessary approvals to maintain their market dominance. As an example, in October 2022, the U.S. Food and Drug Administration (FDA) gave approval to the company’s BOOSTRIX, a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap). This vaccine, which is administered by injection into the upper arm muscle, is utilized during pregnancy to protect newborn infants from pertussis (whooping cough). Studies have shown that Boostrix is not only safe and effective for pregnant women and their offspring, but it also effectively combats pertussis, including its severe forms.

View the full report here:

https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

What Parameters Are Used to Define the Pertussis Vaccine Market?

The pertussis vaccine refers to a vaccine that protects against whooping cough (pertussis), which is a highly contagious respiratory disease caused by the bacterium Bordetella pertussis. It is designed to stimulate the immune system to produce protective antibodies against the pertussis bacterium, thus reducing the risk of infection and its associated symptoms.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13023

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model